Jupiter Neurosciences
Jupiter Neurosciences: A biotech firm specializing in treatments for Alzheimer's and rare diseases.
Founded
2015Jupiter Neurosciences: A biotech firm specializing in treatments for Alzheimer's and rare diseases.
Jupiter Neurosciences, founded with the mission to significantly impact patients and society, is a biotechnology company specializing in treatments for Alzheimer's disease and rare neurological disorders. The company focuses on developing JOTROL™, a clinical-stage drug platform aimed at treating neuroinflammation. Utilizing their proprietary Micellar Technology, Jupiter Neurosciences has created the first resveratrol product that safely reaches therapeutic levels without gastrointestinal side effects, opening up treatment possibilities for various conditions.
Notable figures affiliated with Jupiter Neurosciences include experts in neurology and biotechnology, although specific names are not provided. The company has attracted attention from investors interested in innovative treatments for neurodegenerative diseases. Key achievements include advancing JOTROL™ to clinical stages and demonstrating its potential to safely treat neuroinflammation. Jupiter Neurosciences' impact lies in its pioneering approach to addressing unmet medical needs in both common and rare neurological disorders.
Companies similar to Jupiter Neurosciences include Jupiter Therapeutics, Jupiter Biomedical Research, Intellect Neurosciences and Reservoir Neuroscience.
Jupiter Neurosciences was founded in 2015.
Jupiter Neurosciences' headquarters is located in Jupiter, FL, US.
Jupiter Neurosciences' most recent funding round was for $11M (USD) in December 2024.
As of Dec 1, 2024, Jupiter Neurosciences has disclosed funding of $13.8M (USD). Undisclosed round amounts are excluded.
Jupiter Neurosciences has 15 employees as of Feb 5, 2024.
Reservoir Neuroscience
reservoirneuro.com
